Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript April 29, 2024 4:30 PM ET Company Participants Steven Zenker - VP, IR Dan Chard - Chairman & CEO James Maloney - CFO Conference Call Participants James Salera - Stephens Linda Bolton-Weiser - D.A. Davidson Operator Greetings. Welcome to the Medifast First Quarter 2024 Earnings Conference Call. At this time, all participants are on a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] I will no ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to ________. Commission File Number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) | Delaware | 13-3714405 | ...

BALTIMORE – (BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2024. First Quarter 2024 "Fast paced medical innovation is providing greater access to medical weight loss solutions than ever before. We are transforming our OPTAVIA offer to include comprehensive support for consumers who wish to use GLP-1 medical weight loss solutions on their individual jou ...

Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend," "anticipate," "expect" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's ob ...

Medifast, Inc. (MED) is on track to transition into a diversified health and wellness company. The company continues to invest in customer acquisition and experience to sustain long-term growth. Management is progressing well with the 'Fuel for the Future' program. However, MED is not immune to the volatile macroeconomic environment with inflation.Let’s discuss this in detail.Growth Efforts in PlaceMedifast regularly adapts to shifting consumer behavior to maintain its relevance. To this end, management is ...

Medifast (MED) shares ended the last trading session 5.9% higher at $36.61. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 32.8% loss over the past four weeks.Medifast’s shares have been gaining on optimism surrounding efforts to broaden its presence in the expansive health and wellness market. The company is foraying into popular medically supported weight management and sports nutrition segments. Medifast’s inve ...

Medifast, Inc. (MED) is actively advancing various initiatives to broaden its presence in the expansive health and wellness market. The company is on track with several key initiatives, which include product and program innovation, refinement of coach and client experiences and streamlining operational efficiency, among others. However, management is encountering difficulties in attracting customers, mainly due to macroeconomic elements.Let’s discuss on details.What’s Working in Medifast’s Favor?The Zacks R ...

Don't Get Near These 10%+ Dividend Yield Stocks Tero Vesalainen / iStock via Getty Images Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital appreciation potential are essential for total return expectations.We love dividend stocks here at Wall St. 24/7, especially quality ultra-yield companies that continue to deliver consistent passive income streams for shareho ...

Medifast, Inc. (MED) delivered fourth-quarter 2023 results, with the top and bottom lines declining year over year. However, both earnings and net revenues beat the Zacks Consensus Estimate.Medifast is strategically adjusting its operations to meet the changing demands of the weight loss industry. This involves expanding its customer outreach through enhanced marketing efforts and entering the medically supported weight loss domain in partnership with LifeMD.These steps are designed to increase its market p ...

Medifast, Inc. (NYSE:MED) Q4 2023 Earnings Conference Call February 20, 2024 4:30 PM ET Company Participants Steven Zenker - VP, IR Dan Chard - Chairman & CEO James Maloney - CFO Conference Call Participants James Salera - Stephens Linda Bolton-Weiser - D.A. Davidson Operator Greetings, and welcome to the Medifast Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Oper ...